NO311352B1 - Ny fremgangsmåte for fremstilling av metoprolol - Google Patents
Ny fremgangsmåte for fremstilling av metoprolol Download PDFInfo
- Publication number
- NO311352B1 NO311352B1 NO19992401A NO992401A NO311352B1 NO 311352 B1 NO311352 B1 NO 311352B1 NO 19992401 A NO19992401 A NO 19992401A NO 992401 A NO992401 A NO 992401A NO 311352 B1 NO311352 B1 NO 311352B1
- Authority
- NO
- Norway
- Prior art keywords
- metoprolol
- methoxyethyl
- epichlorohydrin
- base
- resulting
- Prior art date
Links
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 229960002237 metoprolol Drugs 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 9
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 claims description 7
- FAYGEALAEQKPDI-UHFFFAOYSA-N 4-(2-methoxyethyl)phenol Chemical compound COCCC1=CC=C(O)C=C1 FAYGEALAEQKPDI-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 4
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000002934 diuretic Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical group C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 claims 1
- RGHAZVBIOOEVQX-UHFFFAOYSA-N Metoprolol succinate Chemical compound OC(=O)CCC(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 RGHAZVBIOOEVQX-UHFFFAOYSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 229960002003 hydrochlorothiazide Drugs 0.000 claims 1
- 229960000939 metoprolol succinate Drugs 0.000 claims 1
- 229960001300 metoprolol tartrate Drugs 0.000 claims 1
- WUBVEMGCQRSBBT-UHFFFAOYSA-N tert-butyl 4-(trifluoromethylsulfonyloxy)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(OS(=O)(=O)C(F)(F)F)=CC1 WUBVEMGCQRSBBT-UHFFFAOYSA-N 0.000 claims 1
- 239000012071 phase Substances 0.000 description 6
- 150000002118 epoxides Chemical class 0.000 description 5
- UEOWFGJMGUIGHC-UHFFFAOYSA-N 2-[[4-(2-methoxyethyl)phenoxy]methyl]oxirane Chemical compound C1=CC(CCOC)=CC=C1OCC1OC1 UEOWFGJMGUIGHC-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- BSILSXIRKVLUHB-UHFFFAOYSA-N 4-(2-methoxyethyl)-5-propoxy-7-oxabicyclo[4.1.0]hepta-1(6),2,4-triene Chemical compound C1=C(CCOC)C(OCCC)=C2OC2=C1 BSILSXIRKVLUHB-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9604253A SE9604253D0 (sv) | 1996-11-20 | 1996-11-20 | New manufacturing process metoprolol |
| PCT/SE1997/001926 WO1998022426A1 (en) | 1996-11-20 | 1997-11-18 | New manufacturing process of metoprolol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO992401D0 NO992401D0 (no) | 1999-05-19 |
| NO992401L NO992401L (no) | 1999-07-13 |
| NO311352B1 true NO311352B1 (no) | 2001-11-19 |
Family
ID=20404680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19992401A NO311352B1 (no) | 1996-11-20 | 1999-05-19 | Ny fremgangsmåte for fremstilling av metoprolol |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6252113B1 (cs) |
| EP (1) | EP0942899B1 (cs) |
| JP (1) | JP4039640B2 (cs) |
| KR (1) | KR100544560B1 (cs) |
| CN (1) | CN1128786C (cs) |
| AR (1) | AR010069A1 (cs) |
| AT (1) | ATE234273T1 (cs) |
| AU (1) | AU728270B2 (cs) |
| BR (1) | BR9713370A (cs) |
| CA (1) | CA2269941A1 (cs) |
| CZ (1) | CZ174499A3 (cs) |
| DE (1) | DE69719788T2 (cs) |
| DK (1) | DK0942899T3 (cs) |
| EE (1) | EE03761B1 (cs) |
| EG (1) | EG21158A (cs) |
| ES (1) | ES2193365T3 (cs) |
| HK (1) | HK1022684A1 (cs) |
| HU (1) | HUP0002445A3 (cs) |
| ID (1) | ID21505A (cs) |
| IL (1) | IL129747A (cs) |
| IN (1) | IN187175B (cs) |
| IS (1) | IS1964B (cs) |
| MY (1) | MY119303A (cs) |
| NO (1) | NO311352B1 (cs) |
| NZ (1) | NZ335213A (cs) |
| PL (1) | PL191392B1 (cs) |
| PT (1) | PT942899E (cs) |
| RU (1) | RU2210565C2 (cs) |
| SA (1) | SA97180599B1 (cs) |
| SE (1) | SE9604253D0 (cs) |
| SK (1) | SK281990B6 (cs) |
| TR (1) | TR199901115T2 (cs) |
| TW (1) | TW412513B (cs) |
| UA (1) | UA66769C2 (cs) |
| WO (1) | WO1998022426A1 (cs) |
| ZA (1) | ZA9710005B (cs) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050107635A1 (en) * | 2003-11-14 | 2005-05-19 | Mehra Janakraj K. | Metoprolol manufacturing process |
| US20090247642A1 (en) * | 2005-12-23 | 2009-10-01 | Carmen Arnalot Aguilar | Synthesis and preparations of metoprolol and its salts |
| US20080107726A1 (en) * | 2006-11-01 | 2008-05-08 | Pramod Kharwade | Compositions comprising beta-adrenergic receptor antagonists and diuretics |
| CN101607918B (zh) * | 2008-06-16 | 2014-02-19 | 北京德众万全药物技术开发有限公司 | 一种美托洛尔的制备方法 |
| WO2011056929A1 (en) * | 2009-11-04 | 2011-05-12 | Massachusetts Institute Of Technology | Continuous flow synthesis of amino alcohols using microreactors |
| WO2011109276A1 (en) | 2010-03-01 | 2011-09-09 | Massachussets Institute Of Technology | Epoxidation catalysts |
| CN102381995B (zh) * | 2010-08-31 | 2015-04-15 | 扬子江药业集团北京海燕药业有限公司 | 美托洛尔的制备方法 |
| CN102432476A (zh) * | 2010-09-29 | 2012-05-02 | 湖南康普医药研究院 | 一种规模化制备琥珀酸美托洛尔的方法 |
| CN102503843B (zh) * | 2011-10-28 | 2013-10-23 | 山东阿如拉药物研究开发有限公司 | 一种美托洛尔盐的制备方法 |
| KR101379383B1 (ko) * | 2012-03-23 | 2014-04-02 | 주식회사 알에스텍 | 고순도 ⒮―메토프롤롤의 제조방법 |
| CN103980134B (zh) * | 2014-05-30 | 2015-09-30 | 安徽省新星药物开发有限责任公司 | 一种琥珀酸s-美托洛尔的制备方法 |
| CN105820057B (zh) * | 2016-04-22 | 2017-09-29 | 上海应用技术学院 | 一种制备美多心安的方法 |
| CN106543015A (zh) * | 2016-11-07 | 2017-03-29 | 上海应用技术大学 | 一种美多心安的制备方法 |
| CN108299279B (zh) * | 2018-02-09 | 2021-03-23 | 北京梅尔森医药技术开发有限公司 | 取代芳基胺醇化合物及其制备方法和用途 |
| US10744087B2 (en) | 2018-03-22 | 2020-08-18 | Incarda Therapeutics, Inc. | Method to slow ventricular rate |
| CN111018724B (zh) * | 2019-12-27 | 2022-11-08 | 江西美晶科技有限公司 | 一种美托洛尔及其制备方法 |
| CN112645827A (zh) * | 2020-12-25 | 2021-04-13 | 浙江普洛家园药业有限公司 | 一种连续合成美多心安及其盐的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2011584A6 (es) * | 1989-05-26 | 1990-01-16 | Esteve Quimica Sa | Procedimiento industrial para la obtencion de una ariloxipropanolamina. |
| DE69212646T2 (de) | 1991-03-18 | 1997-03-13 | Sepracor Inc | Zubereitung und verfahren enthaltend optisch reines s-metoprolol |
-
1996
- 1996-11-18 NZ NZ335213A patent/NZ335213A/en unknown
- 1996-11-20 US US08/973,144 patent/US6252113B1/en not_active Expired - Lifetime
- 1996-11-20 SE SE9604253A patent/SE9604253D0/xx unknown
-
1997
- 1997-10-23 TW TW086115698A patent/TW412513B/zh active
- 1997-11-06 ZA ZA9710005A patent/ZA9710005B/xx unknown
- 1997-11-12 SA SA97180599A patent/SA97180599B1/ar unknown
- 1997-11-13 IN IN3275DE1997 patent/IN187175B/en unknown
- 1997-11-18 PL PL333541A patent/PL191392B1/pl not_active IP Right Cessation
- 1997-11-18 TR TR1999/01115T patent/TR199901115T2/xx unknown
- 1997-11-18 EG EG122697A patent/EG21158A/xx active
- 1997-11-18 AT AT97913641T patent/ATE234273T1/de not_active IP Right Cessation
- 1997-11-18 DK DK97913641T patent/DK0942899T3/da active
- 1997-11-18 CZ CZ991744A patent/CZ174499A3/cs unknown
- 1997-11-18 SK SK564-99A patent/SK281990B6/sk unknown
- 1997-11-18 ES ES97913641T patent/ES2193365T3/es not_active Expired - Lifetime
- 1997-11-18 PT PT97913641T patent/PT942899E/pt unknown
- 1997-11-18 RU RU99109477/04A patent/RU2210565C2/ru not_active IP Right Cessation
- 1997-11-18 WO PCT/SE1997/001926 patent/WO1998022426A1/en not_active Application Discontinuation
- 1997-11-18 AU AU50776/98A patent/AU728270B2/en not_active Ceased
- 1997-11-18 HU HU0002445A patent/HUP0002445A3/hu unknown
- 1997-11-18 DE DE69719788T patent/DE69719788T2/de not_active Expired - Fee Related
- 1997-11-18 IL IL12974797A patent/IL129747A/xx not_active IP Right Cessation
- 1997-11-18 ID IDW990343D patent/ID21505A/id unknown
- 1997-11-18 EE EEP199900202A patent/EE03761B1/xx not_active IP Right Cessation
- 1997-11-18 EP EP97913641A patent/EP0942899B1/en not_active Expired - Lifetime
- 1997-11-18 UA UA99042412A patent/UA66769C2/uk unknown
- 1997-11-18 JP JP51107298A patent/JP4039640B2/ja not_active Expired - Fee Related
- 1997-11-18 KR KR1019997004401A patent/KR100544560B1/ko not_active IP Right Cessation
- 1997-11-18 CN CN97199796A patent/CN1128786C/zh not_active Expired - Lifetime
- 1997-11-18 BR BR9713370A patent/BR9713370A/pt not_active Application Discontinuation
- 1997-11-18 CA CA002269941A patent/CA2269941A1/en not_active Abandoned
- 1997-11-19 MY MYPI97005544A patent/MY119303A/en unknown
- 1997-11-19 AR ARP970105420A patent/AR010069A1/es unknown
-
1999
- 1999-04-26 IS IS5034A patent/IS1964B/is unknown
- 1999-05-19 NO NO19992401A patent/NO311352B1/no unknown
-
2000
- 2000-03-20 HK HK00101688A patent/HK1022684A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO311352B1 (no) | Ny fremgangsmåte for fremstilling av metoprolol | |
| US7227021B2 (en) | Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid | |
| NO165496B (no) | Analogifremgangsmaate for fremstilling av nye epoksysteroider. | |
| Neale et al. | The influence of solvent and chloramine structure on the free-radical rearrangement products of N-chlorodialkylamines | |
| US6150528A (en) | Method for producing 5-aminomethyl-2-chloropyridines | |
| EP0169602B1 (en) | Preparation of n-substituted azetidine 3-carboxylic acid derivatives | |
| US4289907A (en) | Process for preparing N-alkyl-nitroanilines | |
| KR0143988B1 (ko) | 2-클로로-5-아미노메틸-피리딘의 제조방법 | |
| CA1182819A (en) | Process producing 2,4-diamin-(3,5-dimethoxy-4- methoxy-ethoxy-benzyl)-pyrimidine | |
| MXPA99004570A (en) | New manufacturing process of metoprolol | |
| US4395572A (en) | Process for preparing N-alkyl-nitroanilines | |
| US5973169A (en) | Ipriflavone preparation process | |
| NO885185L (no) | Fremgangsmaate til fremstilling av alkanolaminderivater. | |
| IE47805B1 (en) | 2,3-dihydro-4h-1-benzopyran-4-one o-carbamoyl oximes | |
| WO2005077927A1 (en) | One pot synthesis of citalopram from 5-cyanophthalide | |
| US7501515B2 (en) | Polymorphic form of 17-β-(N-ter. butyl carbamoyl)-4-aza-5-α-androst-1-en-3-one | |
| EP1044960B1 (en) | Process for the preparation of 1,1,1-trifluoro-2-aminoalkanes | |
| EP0579096B1 (en) | A process for the preparation of 5-(3-tert.-butylamino-2-hydroxypropoxy)-3,4-dihydro- carbostyryl. | |
| CN116924973A (zh) | 一种3-氯-2-氨甲基-5-三氟甲基吡啶盐酸盐的制备方法 | |
| NO148450B (no) | Fremgangsmaate ved fremstilling av 1-(2,6-dimethylfenoxy)-2-amino-propan. | |
| NO813067L (no) | Fremgangsmaate ved fremstilling av apovincaminsyreestere | |
| JP2018503640A (ja) | ４−シアノピペリジン塩酸塩を調製する方法 | |
| NO316069B1 (no) | Fremgangsmåte for fremstilling av 2-(2-brometyl)-naftalen | |
| GB2153826A (en) | Unsaturated carboxylic acid |